Christian Blin

Christian Blin currently serves as Président at Daiichi Sankyo Oncology France since May 2024, where the role involves supporting the development of Global R&D capacity and capabilities while concurrently leading Global R&D Finance & Procurement. In addition to this position, Christian Blin has held the title of Senior Vice-President, Head of Global R&D Finance & Procurement at Daiichi Sankyo, Inc. since April 2018, overseeing the R&D financial plans and ensuring optimization of financial resources in collaboration with Corporate Finance and Senior Management. Prior experience includes Vice-President roles in R&D Finance and Head of Project Finance at Sanofi, as well as various financial management positions at Aventis Pharma and Aventis Cropscience. Christian Blin's extensive background also encompasses leadership roles at Hoechst-Schering AgrEvo and Roussel Uclaf, focusing on financial strategy and management across multiple regions and sectors. Educational background includes studies at NEOMA Business School.